Otrexup and Cosentyx drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Otrexup (methotrexate) and Cosentyx (secukinumab). Common drug interactions include drug ineffective among females and drug ineffective among males.

The phase IV clinical study analyzes what interactions people have when they take Otrexup and Cosentyx. It is created by eHealthMe based on reports of 45 people who take the same drugs from the FDA, and is updated regularly.

What is Otrexup?

Otrexup has active ingredients of methotrexate. eHealthMe is studying from 2,154 Otrexup users. Check the latest studies of Otrexup.

What is Cosentyx?

Cosentyx has active ingredients of secukinumab. It is often used in psoriatic arthritis. eHealthMe is studying from 187,247 Cosentyx users. Check the latest studies of Cosentyx.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 18, 2026

45 people who take Otrexup and Cosentyx together, and have interactions are studied.

Otrexup and Cosentyx drug interactions.

What are the common drug interactions of Otrexup and Cosentyx, by gender? *:

female:

  1. Drug ineffective
  2. Pain
  3. Nasopharyngitis (inflammation of the nasopharynx)
  4. Hepatitis c
  5. Malaise (a feeling of general discomfort or uneasiness)
  6. Swelling
  7. Neuropathy peripheral (surface nerve damage)
  8. Restless legs syndrome (a powerful urge to move your legs)
  9. Pain in extremity
  10. Abdominal pain upper

male:

  1. Drug ineffective
  2. Fatigue (feeling of tiredness)
  3. Nausea (feeling of having an urge to vomit)
  4. Diarrhoea
  5. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  6. Pneumonia
  7. Cryptococcosis (potentially fatal fungal disease)
  8. Dactylitis (dactylitis or sausage digit is inflammation of an entire digit (a finger or toe), and can be painful)
  9. Drug intolerance (drug sensitivity)
  10. Seronegative arthritis (a joint disease negative for rheumatoid arthritis)

What are the common drug interactions of Otrexup and Cosentyx, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Oral candidiasis (fungal infection of mouth)
  2. Staphylococcal infection (an infection with staphylococcus bacteria)

50-59:

  1. Drug ineffective

60+:

  1. Drug ineffective
  2. Malaise (a feeling of general discomfort or uneasiness)
  3. Fall
  4. Fatigue (feeling of tiredness)
  5. Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
  6. Kidney infection
  7. Muscle strain (an injury to a muscle in which the muscle fibres tear)
  8. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  9. Pain
  10. Pneumonia

What are the existing conditions these people have? *

  1. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 25 people, 55.56%
  2. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 14 people, 31.11%
  3. Seronegative Arthritis (a joint disease negative for rheumatoid arthritis): 6 people, 13.33%
  4. Psoriasis (immune-mediated disease that affects the skin): 6 people, 13.33%
  5. Dactylitis (dactylitis or sausage digit is inflammation of an entire digit (a finger or toe), and can be painful): 6 people, 13.33%

* Approximation only. Some reports may have incomplete information.

Do you take Otrexup and Cosentyx?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Otrexup and Cosentyx:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Otrexup:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cosentyx:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Otrexup and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cosentyx and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on methotrexate and secukinumab (the active ingredients of Otrexup and Cosentyx, respectively), and Otrexup and Cosentyx (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: